UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000041917
Receipt number R000047827
Scientific Title A study on immune cell exhaustion in patients with type 2 diabetes
Date of disclosure of the study information 2020/10/01
Last modified on 2020/09/28 16:25:28

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A study on immune cell exhaustion in patients with type 2 diabetes

Acronym

Immune cell exhaustion in type 2 diabetes patients

Scientific Title

A study on immune cell exhaustion in patients with type 2 diabetes

Scientific Title:Acronym

Immune cell exhaustion in type 2 diabetes patients

Region

Japan


Condition

Condition

type 2 diabetes

Classification by specialty

Endocrinology and Metabolism

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To clarify the involvment of T lymphocyte exhaustion in the weakened immunity in patients with type 2 diabetes

Basic objectives2

Others

Basic objectives -Others

To evaluate the expression of co-inhibitors in type 2 diabetes patients

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

To compare the expression levels of co-inhibitors on peripheral blood T lymphocytes between type 2 diabetes and non-diabetic patients

Key secondary outcomes

To compare the expression levels of co-inhibitors on peripheral blood T lymphocytes before and after the improvement of blood glucose level in type 2 diabetes patients


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

65 years-old >

Gender

Male and Female

Key inclusion criteria

A. diabetes group:
1) hospitalized patients with type 2 diabetes
2) HbA1c>8.5%
3) fasting plasma glucose >160 mg/dL or postprandial plasma glucose >250 mg/dL

B. non-diabetic group:
1) HbA1c<6.0% and fasting plasma glocose <110 mg/dL
2) no past history of diabetes mellitus

Key exclusion criteria

1) patients with active chronic infectious diseases such as tuberculosis
2) patients with acute infectious diseases such as pneumonia
3) patients with history of chronic inflammatorys diseases such as rheumatoid arthritis
4) patients with history of cancer
5) immunodeficient patients such as those with AIDS
6) patients taking immunosuppressant, steroids, and anti-cancer drugs
7) pregnant, potentially pregnant or lactating women
8) patients with moderate renal dysfunction (male serum creatinin 1.3 mg/dL or higher, female 1.2 mg/dL or higher)

Target sample size

60


Research contact person

Name of lead principal investigator

1st name Isao
Middle name
Last name Usui

Organization

Dokkyo Medical University

Division name

Department of Endocrinology and Metabolism

Zip code

321-0293

Address

880 Kita-Kobayashi Mibu-machi Shimotsuga-gun Tochigi

TEL

0282-87-2150

Email

isaousui@dokkyomed.ac.jp


Public contact

Name of contact person

1st name Isao
Middle name
Last name Usui

Organization

Dokkyo Medical University

Division name

Department of Endocrinology and Metabolism

Zip code

321-0293

Address

880 Kita-Kobayashi Mibu-machi Shimotsuga-gun Tochigi

TEL

0282-87-2150

Homepage URL


Email

isaousui@dokkyomed.ac.jp


Sponsor or person

Institute

Department of Endocrinology and Metabolism, Dokkyo Medical University

Institute

Department

Personal name



Funding Source

Organization

Dokkyo Medical University

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Dokkyo Medical University

Address

880 Kita-Kobayashi Mibu-machi Shimotsuga-gun Tochigi

Tel

0282-87-2150

Email

isaousui@dokkyomed.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2020 Year 10 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2020 Year 07 Month 11 Day

Date of IRB

2020 Year 08 Month 11 Day

Anticipated trial start date

2020 Year 10 Month 01 Day

Last follow-up date

2022 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

We will analyze T lymphocyte function including co-inhibitors in 30 tyep 2 diabetes patients who were hospitalized for a purpose of treating hyperglycemia. As a normal control, the same analysis will be performed in 30 patients hospitalizd for the treatment of diseases other than diabetes. For the diabetes patients, the same items will be measured not only at admission but also at discharge with the improvement of hyperglycemia.


Management information

Registered date

2020 Year 09 Month 28 Day

Last modified on

2020 Year 09 Month 28 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000047827


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name